Scarica l'app Stockscreener
4.025
0.88%
0.035
Precedente Chiudi:
$3.99
Aprire:
$4
Volume 24 ore:
3,732
Relative Volume:
0.00
Capitalizzazione di mercato:
$98.79M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.12%
1M Prestazione:
-12.50%
6M Prestazione:
+50.75%
1 anno Prestazione:
+0.37%
Intervallo 1D:
$3.89
$4.03
Intervallo di 1 settimana:
$3.62
$4.11
Portata 52W:
$1.47
$7.36
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Nome
Artiva Biotherapeutics Inc
Settore
Industria
Telefono
(858) 267-4467
Indirizzo
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
4.025 | 97.93M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.80 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.16 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
849.42 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.42 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
349.67 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-11 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-08-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Iniziato | Jefferies | Buy |
| 2024-08-13 | Iniziato | Needham | Buy |
| 2024-08-13 | Iniziato | TD Cowen | Buy |
| 2024-08-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Artiva Biotherapeutics Inc Borsa (ARTV) Ultime notizie
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $19.00 Average PT from Brokerages - Defense World
ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics executes RSU exchange for employees - MSN
Trading Action: Is Artiva Biotherapeutics Inc stock a good pick for beginnersJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Hedge Fund Bets: Is CFRPRB stock heavily shortedTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Decline in Short Interest - MarketBeat
Pharma News: Can AGMH outperform under higher oil pricesTrade Exit Report & Technical Entry and Exit Tips - baoquankhu1.vn
Brokers Set Expectations for ARTV FY2030 Earnings - Defense World
Income Plays: Is Artiva Biotherapeutics Inc.’s ROE strong enoughJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - mfd.ru
Update Report: Can Artiva Biotherapeutics Inc. outperform in the next rallyJuly 2025 Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Undervalued Penny Stocks To Consider In January 2026 - simplywall.st
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY) - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Contin - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at - GlobeNewswire
Take Profit: Is Artiva Biotherapeutics Inc part of any ETF2025 Price Targets & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Catalysts: How do insiders feel about Artiva Biotherapeutics IncJuly 2025 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Take Profit: Can Artiva Biotherapeutics Inc outperform in the next rallyWeekly Market Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Wall Street Recap: Is AppTech Payments Corp Equity Warrant attractive for institutional investorsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Trend Recap: Will Artiva Biotherapeutics Inc outperform its industry peers2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Artiva Biotherapeutics Stock: Upcoming Data Presentations In Focus (NASDAQ:ARTV) - Seeking Alpha
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Growth in Short Interest - MarketBeat
Published on: 2026-01-14 12:03:58 - baoquankhu1.vn
Quarterly Trades: Will Artiva Biotherapeutics Inc. stock gain from lower inflationWeekly Profit Recap & AI Powered Trade Plan Recommendations - Bộ Nội Vụ
Valuation Update: Can Pineapple Financial Inc be recession proofQuarterly Investment Review & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Published on: 2026-01-14 05:34:55 - baoquankhu1.vn
Sjogren’s Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics - Barchart.com
Bearish Setup: Will EWCZ stock benefit from green energy trends2025 Price Targets & Accurate Entry and Exit Point Alerts - Bộ Nội Vụ
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN
Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Review & Low Drawdown Investment Strategies - ulpravda.ru
How Artiva Biotherapeutics Inc. stock performs in weak economyQuarterly Market Summary & Technical Entry and Exit Tips - Улправда
Is Artiva Biotherapeutics Inc. stock oversold or undervaluedQuarterly Risk Review & Growth Focused Investment Plans - ulpravda.ru
Is Artiva Biotherapeutics Inc. stock a good choice for value investorsOil Prices & Stepwise Swing Trade Plans - Улправда
How Artiva Biotherapeutics Inc. stock performs in high volatility marketsJuly 2025 Sentiment & Proven Capital Preservation Methods - Улправда
NanoSyrinx Appoints New CEO to Advance Nanosyringe Technology - Intellectia AI
Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3% – Should You Buy? - Defense World
Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3%Should You Buy? - MarketBeat
Artiva Biotherapeutics expands board with industry veteran - MSN
Genelux Corporation Announces Appointment of Jason Litten as Chief Medical Officer, Effective January 2, 2026 - marketscreener.com
New medical chief to guide late-stage trials for cancer immunotherapy - Stock Titan
Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO’s Latest Insider Share Sale - Yahoo Finance
Will Artiva Biotherapeutics Inc. stock deliver long term returnsMarket Risk Summary & Reliable Entry Point Alerts - Улправда
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - MSN
Is Artiva Biotherapeutics Inc. stock undervalued vs historical averagesJuly 2025 PreEarnings & Technical Pattern Based Signals - DonanımHaber
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) dropped from NASDAQ Biotechnology Index - marketscreener.com
CEO Moves: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Big Picture & High Accuracy Swing Entry Alerts - Улправда
Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
Resistance Check: Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Safe Entry Trade Signal Reports - Улправда
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics CEO sells $19,122 in stock By Investing.com - Investing.com Nigeria
Artiva Biotherapeutics Inc Azioni (ARTV) Dati Finanziari
Non sono disponibili dati finanziari per Artiva Biotherapeutics Inc (ARTV). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):